RCM
MEDP icon

Riverhead Capital Management’s Medpace MEDP Stock Holding History

Riverhead Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$445K Hold
5,300
– – 0.02% 767
2019
Q2 		$347K Hold
5,300
– – 0.01% 901
2019
Q1 		$312K Buy
+5,300
New +$317K 0.01% 923

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverhead Capital Management's MEDP Position: Q3 2019 in Review

Riverhead Capital Management held its Medpace (MEDP) position steady in Q3 2019 at 5,300 shares worth $445K. The position accounts for 0.02% of the portfolio, ranked #767.

Riverhead Capital Management first reported a position in MEDP in Q1 2019 and has held it in 3 quarters since. 268 funds tracked by Wall St. Rank hold MEDP as of Q3 2019.

  • Riverhead Capital Management held 5,300 shares of Medpace worth $445K as of Q3 2019.
  • Riverhead Capital Management left its Medpace share count unchanged in Q3 2019.
  • Medpace made up 0.02% of Riverhead Capital Management's portfolio in Q3 2019, its #767 holding.
  • Riverhead Capital Management first reported a position in Medpace in Q1 2019 and has held it in 3 quarters since.
  • 268 funds tracked by Wall St. Rank held Medpace as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.